BioRestorative Therapies, Inc. 8-K

What Happened
BioRestorative Therapies, Inc. announced on April 23, 2026 (Form 8-K, Item 7.01) that it has made an updated corporate investor presentation available for use at conferences and investor meetings. The presentation is posted on the company website (www.biorestorative.com) and is furnished as Exhibit 99.1 to the 8-K. The disclosure was furnished under Regulation FD, not filed.

Key Details

• Date of disclosure: April 23, 2026.
• Document: Updated corporate/investor presentation (Exhibit 99.1).
• Availability: Posted on BioRestorative’s website for investor and conference use.
• Regulatory note: Information is furnished under Regulation FD (Item 7.01), meaning it was broadly disclosed rather than filed as part of the registration statement.

Why It Matters
An updated investor presentation gives shareholders and the market the company’s current messaging on strategy, programs, and clinical or business progress. Because the material was furnished under Regulation FD, it reflects information the company intends to distribute publicly (not confidential filings). Investors should review the presentation on the company website for any new program timelines, clinical updates, or corporate priorities that could affect investment decisions.